Literature DB >> 2870833

Thermogenesis in human skeletal muscle as measured by direct microcalorimetry and muscle contractile performance during beta-adrenoceptor blockade.

B Fagher, H Liedholm, M Monti, U Moritz.   

Abstract

The influence of beta-adrenoceptor-blockade on skeletal muscle was studied in ten healthy males with propranolol, atenolol and pindolol randomly given for 8 days each in a cross-over double blind test. After 7 days on each drug, muscle function was tested by an isokinetic dynamometer. Thermogenesis in biopsy samples taken from vastus lateralis muscle after a low grade exercise was studied after 8 days on each drug by direct calorimetry with a perfusion microcalorimeter. Before drug administration, a median heat production rate of 0.67 mW/g of muscle was measured. This value was significantly reduced by 25% during propranolol, but no significant change was found during atenolol or pindolol administration. Peak torque decline during isokinetic endurance test changed significantly in knee flexor but not in extensor muscles, from 15% to 27% after propranolol and from 15% to 23% after pindolol. Maximum dynamic strength was unaltered. Our data suggest that blockade of sympathetic beta 2-receptors decreases thermogenesis in human skeletal muscle and impairs isokinetic endurance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2870833     DOI: 10.1042/cs0700435

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  13 in total

1.  The nuclear receptor, Nor-1, markedly increases type II oxidative muscle fibers and resistance to fatigue.

Authors:  Michael A Pearen; Natalie A Eriksson; Rebecca L Fitzsimmons; Joel M Goode; Nick Martel; Sofianos Andrikopoulos; George E O Muscat
Journal:  Mol Endocrinol       Date:  2012-01-26

Review 2.  Expenditure and storage of energy in man.

Authors:  E A Sims; E Danforth
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

Review 3.  Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease.

Authors:  Michael A Pearen; George E O Muscat
Journal:  Mol Endocrinol       Date:  2010-04-14

4.  Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.

Authors:  T Pollare; H Lithell; I Selinus; C Berne
Journal:  BMJ       Date:  1989-04-29

5.  Regulation of intracellular cyclic AMP in skeletal muscle cells involves the efflux of cyclic nucleotide to the extracellular compartment.

Authors:  Rosely Oliveira Godinho; Valter Luiz Costa
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

6.  Skeletal muscle expresses the extracellular cyclic AMP-adenosine pathway.

Authors:  T Chiavegatti; V L Costa; M S Araújo; R O Godinho
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

7.  Effects of terbutaline on basal thermogenesis of human skeletal muscle and Na-K pump after 1 week of oral use--a placebo controlled comparison with propranolol.

Authors:  B Fagher; H Liedholm; A Sjögren; M Monti
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

8.  Transgenic muscle-specific Nor-1 expression regulates multiple pathways that effect adiposity, metabolism, and endurance.

Authors:  Michael A Pearen; Joel M Goode; Rebecca L Fitzsimmons; Natalie A Eriksson; Gethin P Thomas; Gary J Cowin; S-C Mary Wang; Zewen K Tuong; George E O Muscat
Journal:  Mol Endocrinol       Date:  2013-09-24

9.  Effects of propranolol and exercise training in children with severe burns.

Authors:  Laura J Porro; Ahmed M Al-Mousawi; Felicia Williams; David N Herndon; Ronald P Mlcak; Oscar E Suman
Journal:  J Pediatr       Date:  2012-10-17       Impact factor: 4.406

10.  Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm.

Authors:  Michael A Pearen; James G Ryall; Gordon S Lynch; George Eo Muscat
Journal:  BMC Genomics       Date:  2009-09-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.